• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Basic Research of Biosynthesis of neocarzinostatin chromophore, one of super natural product

Research Project

Project/Area Number 09672149
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Chemical pharmacy
Research InstitutionFukushima Medical University

Principal Investigator

EDO Kiyoto  Fukushima Medical University, Dept. of Medicine, Associate Professor, 医学部, 助教授 (40125505)

Project Period (FY) 1997 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 1999: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1998: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1997: ¥1,200,000 (Direct Cost: ¥1,200,000)
KeywordsNeocarzinostatin chromophore / antitumor antibiotic / biosynthesis / bicyclododeca-dienediyne / 2-hydroxy-7-methoxy-5-methyl-1-naphthalenecarboxylic acid / ネオカルチノスタチン クロモフォア / エンジイン構造 / ネオカルチノスタチン / 制痒性抗生物質
Research Abstract

In this research, the biosynthesis of NCS-chr core (DEDY) part was basically investigated. The analysis of composition of fatty acids derived from NCS producing F-41 strain was conducted. Iso-CィイD216:1ィエD2(ΔィイD19ィエD1) (10%-20% of total fatty acid fraction), a rare fatty acid, was detected by GC-MS, whereas the analysis of fatty acids composition derived from NCS unproducing F-41 strain iso-CィイD216:1ィエD2(ΔィイD19ィエD1) was negligible. In addition, total fatty acids fraction binding NA was isolated. But, it was impossible to purify this fatty acid fraction binding with NA to single compounds because this fraction was very labile as well as parent compound, NCS-chr.
The antitumor antibiotic neocarzinostatin composes of a protein and a non-protein chromophore (NCS-chr) at a molar ratio 1:1. This very labile NCS-chr is responsible for the biological activities of the parent compound. The chemical structure of this chromophore was elucidated as a bicyclo [7, 3, 0] dodecadienediyne (DEDY) system … More having 2-hydroxy-7-methxy-5-methyl-1-naphthalenecarboxylic acid (NA), N-methylfucosamine (MF), ethylene carbonate (EC) and high strained epoxide (SE).
The biosynthetic pathway of NCS-chr was reported on the basis of the incorporation of the ィイD113ィエD1C labeled acetate precursors by Hensens. The acetate incorporation results suggested that the NA was derived from a hexaketide and DEDY ring system from a oleate or creptenyate.
Above observations, it is suggested that the key compound of the biosynthetic pathway of NCS-chr was very labile unsaturated fatty acid having a NA moiety. And it can be presumed that after this unsaturated fatty acid coupled with MF, and then both SE and EC moieties might introduce to this fatty acid by epoxidation and carbonation, respectively.
In addition, squalene, dehydrosqualene, tetrahydrosualene, diploptene was isolated and bactriohopanes were detected in organic solvent extract of F-41 strain. But, the role of these squalenes and hopanoids concerning NCS-chr biosynthesis is now unclear Less

Report

(4 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • 1997 Annual Research Report
  • Research Products

    (3 results)

All Other

All Publications (3 results)

  • [Publications] H. maeda, K. Edo, N. Isida(Eds): "Neocarzinostatin-The past, Present, and Future of an Anticander Drug"Springer. 287 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Maeda, K. Edo and N. Ishida (Eds): "Neocarzinostatin the past Present and Future of an Anticancer Drug" Springer, 287 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] H.Maeda,K.Edo and N.Ishida(Eds): "Neocarzinostatin the past,Present,and Future of an Anticancer Drug" Springer, 287 (1997)

    • Related Report
      1997 Annual Research Report

URL: 

Published: 1997-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi